Partnering

In these areas, we are interested in a variety of partnering activities including M&A, intellectual property licensing, commercial partnerships, research and development, and clinical collaboration.

Examples of partnering:

Testing Services

• CareDx Collaborates with Weill Cornell Medicine to Lead the Development and Commercialization of UroMap
• CareDx and Veracyte Announce Exclusive Partnership for Transplant Rejection Testing on nCounter System
• CareDx Announces AlloID and Exclusive Partnership with IDbyDNA

Transplant Lab Products

• CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular
• CareDx Initiates Acquisition Proceedings and Allenex

Digital Transplant Solutions

• CareDx Agrees to Acquire OTTR Complete Transplant Management
• CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers
• CareDx To Acquire Transplant Hero Medication Management Application
• CareDx Acquires MedActionPlan to Directly Support Patients with Better Adherence
• CareDx Expands Its Medication Adherence Services with the Acquisition of The Transplant Pharmacy

We are actively seeking biopharma partners preparing for or running clinical trials in solid organ, hematopoietic stem cell transplant or allogeneic cell therapies where CareDx’s services and products can help to build early evidence of drug efficacy.

Our Pharma Services

• AlloCell^®, a pharmacokinetic monitoring solution for allogeneic cell therapy products
• AlloHeme^®, a chimerism monitoring solution post-hematopoietic stem cell transplant
• AlloSure^®, a circulating cell-free DNA solution post solid organ transplant
• AlloSeq^® HCT Tx17, a HLA typing service solution
• AlloMap^®, solution to measure immune quiescence post-transplant

We have a growing list of service offerings and can develop bespoke solutions.  Please enquire with our Business Development team about a solution that fits your needs.

Examples of partnering:

• CareDx and Eledon Pharmaceuticals Announce Collaborative Research Agreement, October 19, 2021
• CareDx Partners with Multiple Biotechnology Companies to Use AlloCell in CAR T-Cell Therapy Clinical Studies

• Become a partner in solid organ transplant and cellular therapy by bringing innovative monitoring solutions to the clinic
• Remain focused on allo-transplant patients by improving the cell transplant treatment model
• Create flexibility that helps bring technology from around the world right into the clinic